Search and Browse
Download
Enter Data
| Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333260 ((2S,3R,4S)-2-(8-((3,5-dichlorobenzyl)amino)-[1,2,4...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | <10 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333214 ((2S,3R,4S)-2-(8-((3-(trifluoromethyl)benzyl)amino)...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | <10 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333208 ((2S,3R,4S)-2-(8-(piperidin-1-yl)-[1,2,4]triazolo[4...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | <10 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333227 ((2S,3R,4S)-2-(8-((pyridin-4-ylmethyl)amino)-[1,2,4...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | <10 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333228 ((2S,3R,4S)-2-(8-((furan-3-ylmethyl)amino)-[1,2,4]t...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | <10 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333246 ((2S,3R,4S)-2-(8-((4-methylpiperazin-1-yl)amino)-[1...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | <10 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333259 ((2S,3R,4S)-2-(8-(2-(3-chlorophenyl)hydrazinyl)-[1,...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | <10 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333261 ((2S,3R,4S)-2-(8-((2,5-dichlorobenzyl)amino)-[1,2,4...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | <10 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333210 ((2S,3R,4S)-2-(8-(benzylamino)-[1,2,4]triazolo[4,3-...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 55 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333240 ((2S,3R,4R)-2-(8-((3-chlorobenzyl)amino)-[1,2,4]tri...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 55 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333238 ((2S,3R,4S)-2-(8-((2-morpholinoethyl)amino)-[1,2,4]...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 55 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333254 ((2S,3R,4S)-2-(8-((4-iodobenzyl)amino)-[1,2,4]triaz...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 55 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333237 ((2S,3R,4S)-2-(8-(isopentylamino)-[1,2,4]triazolo[4...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 55 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333215 ((2S,3R,4S)-2-(8-((thiophen-3-ylmethyl)amino)-[1,2,...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 55 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333230 ((2S,3R,4S)-2-(8-((3-bromophenethyl)amino)-[1,2,4]t...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 55 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333258 ((2S,3R,4S)-2-(8-hydroxy-[1,2,4]triazolo[4,3-a]pyra...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 55 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333226 ((2S,3R,4S)-2-(8-((pyridin-3-ylmethyl)amino)-[1,2,4...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 55 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333232 ((2S,3R,4S)-2-(8-((2-phenylcyclopropyl)amino)-[1,2,...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 55 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333243 ((2S,3R,4R)-2-(8-((3-iodobenzyl)amino)-[1,2,4]triaz...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 55 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333250 ((2S,3R,4S)-2-(8-(((S)-1-(3-chlorophenyl)ethyl)amin...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 55 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333262 ((2S,3R,4S)-2-(8-((thiophen-2-ylmethyl)amino)-[1,2,...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 55 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333211 ((2S,3R,4S)-2-(8-((3-iodobenzyl)amino)-[1,2,4]triaz...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 55 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333217 ((2S,3R,4S)-2-(8-((3-methylbenzyl)amino)-[1,2,4]tri...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 55 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333247 ((2S,3R,4S)-2-(8-(morpholinoamino)-[1,2,4]triazolo[...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 55 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333212 ((2S,3R,4S)-2-(8-((cyclopropylmethyl)amino)-[1,2,4]...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 55 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333221 (3-(((3-((2S,3R,4S)-3,4-dihydroxytetrahydrothiophen...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 55 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333239 (3-chloro-N-(3-((2S,3R,4S)-3,4-dihydroxytetrahydrot...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 55 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333174 ((2S,3R,4S)-2-(8-((3-chlorobenzyl)amino)-[1,2,4]tri...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 55 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333216 ((2S,3R,4S)-2-(8-(phenethylamino)-[1,2,4]triazolo[4...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 55 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333244 ((2S,3R,4R)-2-(8-((3-chlorophenethyl)amino)-[1,2,4]...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 55 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333252 ((2S,3R,4S)-2-(8-((2-chlorobenzyl)amino)-[1,2,4]tri...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333233 ((2S,3R,4S)-2-(8-((2-(3-chlorophenyl)propan-2-yl)am...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333209 ((2S,3R,4S)-2-(8-morpholino-[1,2,4]triazolo[4,3-a]p...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333225 ((2S,3R,4S)-2-(8-(cyclohexylamino)-[1,2,4]triazolo[...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333222 ((2S,3R,4S)-2-(8-((3-bromobenzyl)amino)-[1,2,4]tria...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333245 (4-(((3-((2S,3R,4S)-3,4-dihydroxytetrahydrothiophen...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333224 ((2S,3R,4S)-2-(8-(cyclopentylamino)-[1,2,4]triazolo...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333263 ((2S,3R,4S)-2-(8-((2,3-dichlorobenzyl)amino)-[1,2,4...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333241 ((2S,3R,4S)-2-(8-((imidazo[1,2-a]pyridin-2-ylmethyl...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333236 ((2S,3R,4S)-2-(8-(cyclopropylamino)-[1,2,4]triazolo...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333220 ((2S,3R,4S)-2-(8-((3-methoxybenzyl)amino)-[1,2,4]tr...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333256 ((2S,3R,4S)-2-(8-((2-(piperidin-1-yl)ethyl)amino)-[...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333249 (2-chloro-4-(((3-((2S,3R,4S)-3,4-dihydroxytetrahydr...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333265 ((2S,3R,4S)-2-(8-((2,4-dichlorobenzyl)amino)-[1,2,4...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333218 ((2S,3R,4S)-2-(8-((3-fluorobenzyl)amino)-[1,2,4]tri...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333207 ((2S,3R,4S)-2-(8-(methylamino)-[1,2,4]triazolo[4,3-...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333264 ((2S,3R,4S)-2-(8-((3,4-dichlorobenzyl)amino)-[1,2,4...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333248 ((2S,3R,4S)-2-(8-(((1S,2R)-2-phenylcyclopropyl)amin...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333234 ((2S,3R,4S)-2-(8-((1-(3-chlorophenyl)cyclopropyl)am...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A3 (Homo sapiens (Human)) | BDBM333213 ((2S,3R,4S)-2-(8-(cyclobutylamino)-[1,2,4]triazolo[...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
HANDOK INC. US Patent | Assay Description HEK-293 cell membrane homogenates (32 μg protein), in which A3 adenosine receptors were expressed, are incubated for 120 min at 22° C. with 0.15... | US Patent US10196396 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5HQC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Displayed 1 to 50 (of 240 total ) | Next | Last >> |
